ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN
December 24, 2024 20:33 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of...
AstraZeneca PLC Announcement: If You Have Suffered Losses in AstraZeneca PLC (NASDAQ: AZN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 18, 2024 19:15 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
PARP Inhibitor Market to Surpass USD 67.0 Billion by 2034, with 18.30% CAGR and Redefining Cancer Treatment Landscape - By PMI
February 27, 2024 14:30 ET
|
PMI
Covina, Feb. 27, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the PARP Inhibitor Market size was valued at about USD 12.5 Billion in 2024 and expected to grow at CAGR of 18.30%...
Alzheimer's Disease Diagnostics and Therapeutics Market Revenues to Reach USD 9.31 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
August 08, 2023 09:30 ET
|
Mordor Intelligence
Hyderabad, Aug. 08, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Alzheimer's Disease Diagnostics and Therapeutics Market Report (2023-2028)," the market is estimated at...
Peptide Therapeutics Market is estimated to be US$ 66.18 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
July 04, 2022 09:43 ET
|
PMI
Covina, July 04, 2022 (GLOBE NEWSWIRE) -- The joining of two or more amino acid monomers via amide bonds forms peptides. The size of a peptide is what separates it from a protein. Peptides are...
AZN INVESTOR NOTICE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline in Securities Class Action – AZN
March 18, 2021 20:15 ET
|
The Rosen Law Firm PA
NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and...
BREAKING NEWS: ROSEN, NATIONAL TRIAL COUNSEL, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline – AZN
February 10, 2021 17:30 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and...
Global Psoriatic Arthritis Market – Rise in Prevalence of Psoriasis & Psoriatic Arthritis Disease & Increasing Government Healthcare Expenses are some of the factors driving market growth - by PMI
December 24, 2020 11:35 ET
|
PMI
Covina, CA, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Psoriatic arthritis is a chronic degenerative condition associated with psoriasis. In the absence of proper and timely treatment, the disease may lead...